Literature DB >> 21824144

FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing.

Jaehong Suh1, Alvin Lyckman, Lirong Wang, Elizabeth A Eckman, Suzanne Y Guénette.   

Abstract

Amyloid precursor protein (APP) family members and their proteolytic products are implicated in normal nervous system function and Alzheimer's disease pathogenesis. APP processing and Aβ secretion are regulated by neuronal activity. Various data suggest that NMDA receptor (NMDAR) activity plays a role in both non-amyloidogenic and amyloidogenic APP processing depending on whether synaptic or extrasynaptic NMDARs are activated, respectively. The APP-interacting FE65 proteins modulate APP trafficking and processing in cell lines, but little is known about their contribution to APP trafficking and processing in neurons, either in vivo or in vitro. In this study, we examined the contribution of the FE65 protein family to APP trafficking and processing in WT and FE65/FE65L1 double knockout neurons under basal conditions and following NMDAR activation. We report that FE65 proteins facilitate neuronal Aβ secretion without affecting APP fast axonal transport to pre-synaptic terminals. In addition, FE65 proteins facilitate an NMDAR-dependent non-amyloidogenic APP processing pathway. Generation of high-molecular weight (HMW) species bearing an APP C-terminal epitope was also observed following NMDAR activation. These HMW species require proteasomal and calpain activities for their accumulation. Recovery of APP polypeptide fragments from electroeluted HMW species having molecular weights consistent with calpain I cleavage of APP suggests that HMW species are complexes formed from APP metabolic products. Our results indicate that the FE65 proteins contribute to physiological APP processing and accumulation of APP metabolic products resulting from NMDAR activation.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824144      PMCID: PMC3188680          DOI: 10.1111/j.1471-4159.2011.07419.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  53 in total

1.  The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.

Authors:  W T Kimberly; J B Zheng; S Y Guénette; D J Selkoe
Journal:  J Biol Chem       Date:  2001-09-05       Impact factor: 5.157

2.  A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface.

Authors:  Jae Yoon Leem; Carlos A Saura; Claus Pietrzik; John Christianson; Christian Wanamaker; LaShaunda T King; Margaret L Veselits; Taisuke Tomita; Laura Gasparini; Takeshi Iwatsubo; Huaxi Xu; William N Green; Edward H Koo; Gopal Thinakaran
Journal:  Neurobiol Dis       Date:  2002-10       Impact factor: 5.996

3.  The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo.

Authors:  Shasta L Sabo; Annat F Ikin; Joseph D Buxbaum; Paul Greengard
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

Review 4.  Calpain and caspase: can you tell the difference?

Authors:  K K Wang
Journal:  Trends Neurosci       Date:  2000-01       Impact factor: 13.837

5.  Inhibition of neuronal calcium oscillations by cell surface APP phosphorylated on T668.

Authors:  Susana Ferrao Santos; Bernadette Tasiaux; Christian Sindic; Jean-Noël Octave
Journal:  Neurobiol Aging       Date:  2010-02-01       Impact factor: 4.673

6.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

7.  Isoform-specific knockout of FE65 leads to impaired learning and memory.

Authors:  Baiping Wang; Qubai Hu; Mark G Hearn; Kimiko Shimizu; Carol B Ware; Dennis H Liggitt; Lee-Way Jin; Bethany H Cool; Daniel R Storm; George M Martin
Journal:  J Neurosci Res       Date:  2004-01-01       Impact factor: 4.164

8.  Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments.

Authors:  Paul M Mathews; Ying Jiang; Stephen D Schmidt; Olivera M Grbovic; Marc Mercken; Ralph A Nixon
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

9.  Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1.

Authors:  Yang Chang; Giuseppina Tesco; William J Jeong; Loren Lindsley; Elizabeth A Eckman; Christopher B Eckman; Rudolph E Tanzi; Suzanne Y Guénette
Journal:  J Biol Chem       Date:  2003-10-03       Impact factor: 5.157

10.  APP processing is regulated by cytoplasmic phosphorylation.

Authors:  Ming-Sum Lee; Shih-Chu Kao; Cynthia A Lemere; Weiming Xia; Huang-Chun Tseng; Ying Zhou; Rachael Neve; Michael K Ahlijanian; Li-Huei Tsai
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

View more
  9 in total

1.  FE65 and FE65L1 amyloid precursor protein-binding protein compound null mice display adult-onset cataract and muscle weakness.

Authors:  Jaehong Suh; Juliet A Moncaster; Lirong Wang; Imran Hafeez; Joachim Herz; Rudolph E Tanzi; Lee E Goldstein; Suzanne Y Guénette
Journal:  FASEB J       Date:  2015-03-10       Impact factor: 5.191

2.  Packing Density of the Amyloid Precursor Protein in the Cell Membrane.

Authors:  Dennis de Coninck; Thomas H Schmidt; Jan-Gero Schloetel; Thorsten Lang
Journal:  Biophys J       Date:  2018-03-13       Impact factor: 4.033

3.  Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation.

Authors:  Mitsuru Shinohara; Ronald C Petersen; Dennis W Dickson; Guojun Bu
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

4.  The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease?

Authors:  Daniel A Bórquez; Christian González-Billault
Journal:  Int J Alzheimers Dis       Date:  2012-02-09

5.  Phosphorylation of FE65 Ser610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer's disease amyloid precursor protein processing.

Authors:  Wan Ning Vanessa Chow; Jacky Chi Ki Ngo; Wen Li; Yu Wai Chen; Ka Ming Vincent Tam; Ho Yin Edwin Chan; Christopher C J Miller; Kwok-Fai Lau
Journal:  Biochem J       Date:  2015-07-17       Impact factor: 3.857

6.  Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy.

Authors:  F Zeidán-Chuliá; B-H N de Oliveira; A B Salmina; M F Casanova; D P Gelain; M Noda; A Verkhratsky; J C F Moreira
Journal:  Cell Death Dis       Date:  2014-05-22       Impact factor: 8.469

7.  Our "energy-Ca(2+) signaling deficits" hypothesis and its explanatory potential for key features of Alzheimer's disease.

Authors:  Ming Chen; Huey T Nguyen
Journal:  Front Aging Neurosci       Date:  2014-12-03       Impact factor: 5.750

8.  FE65 and FE65L1 share common synaptic functions and genetically interact with the APP family in neuromuscular junction formation.

Authors:  Paul Strecker; Susann Ludewig; Marco Rust; Tabea A Mundinger; Andreas Görlich; Elisa G Krächan; Christina Mehrfeld; Joachim Herz; Martin Korte; Suzanne Y Guénette; Stefan Kins
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

9.  Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription.

Authors:  Jaehong Suh; Donna M Romano; Larissa Nitschke; Scott P Herrick; Britt A DiMarzio; Volodymyr Dzhala; Jun-Seok Bae; Mary K Oram; Yuejiao Zheng; Basavaraj Hooli; Kristina Mullin; Vincenzo A Gennarino; Wilma Wasco; Jeremy D Schmahmann; Mark W Albers; Huda Y Zoghbi; Rudolph E Tanzi
Journal:  Cell       Date:  2019-08-22       Impact factor: 41.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.